BIOMAT Database Logo BIOMAT Database Logo

Secondary prevention of ischemic heart disease: a long-term controlled lidoflazine study. 1979

H De Geest, and H Kesteloot, and J Piessens

UI MeSH Term Description Entries
D008013 Lidoflazine Coronary vasodilator with some antiarrhythmic action. Clinium,Ordiflazine
D008134 Long-Term Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Care, Long-Term,Long Term Care
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H De Geest, and H Kesteloot, and J Piessens
[Secondary prevention of ischemic heart disease].
January 1969, Deutsches medizinisches Journal,
H De Geest, and H Kesteloot, and J Piessens
[Secondary prevention of ischemic heart disease].
August 1979, Voenno-meditsinskii zhurnal,
H De Geest, and H Kesteloot, and J Piessens
[Secondary prevention of ischemic heart disease].
January 1991, Klinicheskaia meditsina,
H De Geest, and H Kesteloot, and J Piessens
[Anti-hyperlipemic therapy in the secondary prevention of coronary heart disease. Long-term study].
January 1974, Bollettino della Societa italiana di cardiologia,
H De Geest, and H Kesteloot, and J Piessens
[Food and secondary prevention of ischemic heart disease].
November 1996, Ugeskrift for laeger,
H De Geest, and H Kesteloot, and J Piessens
[Diet and secondary prevention of ischemic heart disease].
February 1997, Ugeskrift for laeger,
H De Geest, and H Kesteloot, and J Piessens
Primary and secondary prevention of ischemic heart disease.
July 1994, Current opinion in cardiology,
H De Geest, and H Kesteloot, and J Piessens
[Ambulatory treatment experience with lidoflazine in ischemic heart disease].
July 1980, Kardiologiia,
H De Geest, and H Kesteloot, and J Piessens
A LONG-TERM THERAPY OF ISCHEMIC HEART DISEASE.
September 1963, Angiology,
H De Geest, and H Kesteloot, and J Piessens
Long-term hospital-based secondary prevention of coronary artery disease: a randomized controlled trial.
December 2021, BMC cardiovascular disorders,
Copied contents to your clipboard!